<DOC>
	<DOCNO>NCT01211886</DOCNO>
	<brief_summary>Admission BNP useful marker diagnose predict type IV cardio-renal syndrome type IV patient chronic kidney disease admit ICU acute heart failure retrospective study . Therefore , aim prospectively investigate utility serum BNP evaluate treatment adequacy predict future cardiac event patient type IV CRS .</brief_summary>
	<brief_title>Utility Brain Natriuretic Peptide ( BNP ) Patients With Type IV Cardio-renal Syndrome Admitted Intensive Care Unit ( ICU )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Cardio-Renal Syndrome</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Adult patient age &gt; 18 year , Patients chronic kidney disease ( Serum Cr &gt; 2.0 , Documented medical history chronic kidney disease Cardiopulmonary resuscitation , Donotresuscitate state , Acute kidney injury , ICU stay &lt; 1 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Brain natriuretic peptide</keyword>
	<keyword>Cardio-renal syndrome</keyword>
</DOC>